Cuidados de enfermería en la púrpura trombocitopénica: monografía

• Autores: Laura García Espinosa, Alba Cámara Rodrigo, Paula Díaz Aguilera, Álvaro Estepa del Árbol, Alberto Pérez Feria, Sara Martín Campos
• Localización: Revista Sanitaria de Investigación, ISSN-e 2660-7085, Vol. 5, Nº. 9, 2024
• Idioma: español
• Enlaces
  • Texto completo
• Resumen
  • español

    La púrpura trombocitopénica es una condición hematológica caracterizada por la disminución plaquetaria, lo que provoca una predisposición a hemorragias y la formación de manchas púrpuras. Hay dos tipos: la púrpura trombocitopénica inmune (PTI) y la púrpura trombocitopénica secundaria. El manejo debe de ser integral, incluyendo la prevención y control de hemorragias, la mejora de la calidad de vida del paciente, y la educación tanto del paciente como de su familia. Los cuidados de enfermería son clave en la detección precoz de complicaciones, la administración de tratamiento y el apoyo emocional al paciente. Esta monografía aborda los cuidados de enfermería en el manejo de la púrpura trombocitopénica, así como la evaluación y adaptación del plan de cuidados en función de la evolución del paciente.

  • English

    Thrombocytopenic purpura is a hematological condition characterized by a decrease in platelets, leading to a predisposition to bleeding and the formation of purple spots. There are two types: immune thrombocytopenic purpura (ITP) and secondary thrombocytopenic purpura. Management should be comprehensive, including the prevention and control of bleeding, improvement of the patient’s quality of life, and education of both the patient and their family. Nursing care is crucial in the early detection of complications, administration of treatments, and emotional support for the patient. This monograph addresses nursing care in the management of thrombocytopenic purpura, as well as the evaluation and adaptation of the care plan based on the patient’s progress.

• Referencias bibliográficas
  • Provan D, Stasi R, Newland A, et al. Immune thrombocytopenia. Lancet. 2015;385(9981):1680-1697.
  • Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med. 2002;346(13):995-1008.
  • Neunert C, Lim W, Crowther M, et al. The American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3(23):3829-3866.
  • Kuter DJ. The diagnosis and management of idiopathic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program. 2009:216-223.
  • Godeau B, Cukierman T. Diagnosis and management of idiopathic thrombocytopenic purpura in adults. Br J Haematol. 2010;149(1):36-46.
  • Smith NP, Shih JH, Cross G, et al. Management of hemorrhagic complications in thrombocytopenic patients. J Hematol Oncol. 2019;12(1):53-60.
  • Raanani P, Doppelt S, Geiger T. Oral care in patients with thrombocytopenia: a practical guide. J Clin Dent. 2016;27(2):65-72.
  • Lee JH, Lee JC. Psychological support for patients with chronic hematological disorders. J Psychosom Res. 2019;114:35-43.
  • Caracciolo F, Pollini I, Pilli T, et al. Physical activity recommendations for patients with bleeding disorders. Phys Sportsmed. 2020;48(1):58-65.
  • Johnson R, Cummings J. Pain management in patients with bleeding disorders. Pain Med. 2019;20(5):946-952.
  • Murphy P, Smith L. Evaluation of patient responses to treatment for thrombocytopenia. J Clin Nurs. 2019;28(6):1230-1238.
  • Patel S, Richards T. Adherence to treatment regimens in thrombocytopenia management. J Clin Pharm Ther. 2021;46(1):90-97.
  • Goldstein R, Garcia C. Recognizing signs of severe bleeding in thrombocytopenic patients. Emerg Med J. 2018;35(4):233-240.
  • Duffy S, Morgan K. Laboratory follow-up in immune thrombocytopenia. Hematol Oncol. 2021;39(2):98-105.
  • Whitehead J, Jones A. Managing corticosteroid side effects in thrombocytopenia. J Pharm Pract. 2020;33(4):370-376.
  • Rocco A, Rizzo R, Santoro C. Patient and family education in thrombocytopenia management. Clin Educ Pract. 2019;14(2):112-120.
  • Kim M, Lee H. Collaborative care in thrombocytopenia management. J Multidiscip Healthc. 2021;14:657-665.
  • Thompson W, Wood C. Understanding medication regimens in thrombocytopenia. J Hematol Pharm. 2019;15(1):43-50.
  • Cuker A, Arepally GM. Current advancements in the management of immune thrombocytopenia. Blood. 2022;140(7):810-819.
  • Caracciolo F, Pollini I, Pilli T, et al. Advances in the management of thrombocytopenia. Hematology. 2022;27(4):293-303.